Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Organ Transplantation: Is Less Really More?

被引：7

作者：

Avery, Robin K. ^{[1
]}

机构：

[1] Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Cleveland Clin, Med Inst,Dept Infect Dis, Cleveland, OH 44106 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2011年 / 52卷 / 03期

关键词：

RECIPIENTS; DISEASE; GANCICLOVIR; EFFICACY; METAANALYSIS; PREVENTION; SAFETY;

D O I：

10.1093/cid/ciq145

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：322 / 324

页数：3

共 13 条

[1]

Avery R K, 1999, Transpl Infect Dis, V1 Suppl 1, P13

[2] Ganciclovir resistance: a matter of time and titre [J].

Drew, WL .

LANCET, 2000, 356 (9230) :609-610

[3] Experience with low-dose valganciclovir prophylaxis in adult liver transplant recipients [J].

Dupuis, R. ;

Harris, M. ;

Gillis, K. ;

Gerber, D. ;

Fair, J. ;

Watson, R. ;

Koslowski, T. ;

Andreoni, K. .

TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) :3266-3270

[4] The dynamics of human cytomegalovirus replication in vivo [J].

Emery, VC ;

Cope, AV ;

Bowen, EF ;

Gor, D ;

Griffiths, PD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (02) :177-182

[5] Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: A single-center, retrospective analysis [J].

Gabardi, S ;

Magee, CC ;

Baroletti, SA ;

Powelson, JA ;

Cina, JL ;

Chandraker, AK .

PHARMACOTHERAPY, 2004, 24 (10) :1323-1330

[6] Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients [J].

Kalil, AC ;

Levitsky, J ;

Lyden, E ;

Stoner, J ;

Freifeld, AG .

ANNALS OF INTERNAL MEDICINE, 2005, 143 (12) :870-880

[7]

KALIL AC, 2010, CLIN INFECT DIS

[8]

Limaye Ajit P, 2002, Semin Respir Infect, V17, P265, DOI 10.1053/srin.2002.36447

[9] Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants [J].

Limaye, AP ;

Corey, L ;

Koelle, DM ;

Davis, CL ;

Boeckh, M .

LANCET, 2000, 356 (9230) :645-649

[10] INCIDENCE AND RISK-FACTORS ASSOCIATED WITH THE DEVELOPMENT OF CYTOMEGALOVIRUS DISEASE AFTER INTESTINAL TRANSPLANTATION [J].

MANEZ, R ;

KUSNE, S ;

GREEN, M ;

ABUELMAGD, K ;

IRISH, W ;

REYES, J ;

FURUKAWA, H ;

TZAKIS, A ;

FUNG, JJ ;

TODO, S ;

STARZL, TE .

TRANSPLANTATION, 1995, 59 (07) :1010-1014

← 1 2 →